Latest filing published 03 Jun 2026 for Amphastar Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Howard Lee in Amphastar Pharmaceuticals, Inc., where the filings describe the role as board member. Between 20 May 2021 and 2 June 2026, the trades on record add up to 14 filings.
Every open-market trade on record is a sale: 1 sale worth €364k. Besides market trades, the filings include 8 share grants and 5 option exercises.
On 3 June 2026 came the latest disclosure, a share grant for €12k in Amphastar Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations